Shares of SINTX Technologies Inc (NASDAQ:SINT) are trading sharply higher Wednesday morning following study confirming its proprietary silicon nitride possesses broad-spectrum antiviral properties. Here’s what investors need to know.
What To Know: The peer-reviewed research, conducted with Virginia Tech, shows the material is highly effective against multiple virus strains, including SARS-CoV-2 and MERS-CoV.
The study revealed that direct contact inactivated up to 99.97% of SARS-CoV-2 within 10 minutes. Furthermore, it demonstrated 97% inactivation when embedded in textile fabric, highlighting its potential for use in personal protective equipment.
SINTX says potential applications include antiviral face masks, advanced wound dressings and air filtration systems. The company noted that unlike traditional silver or copper additives, its material is non-toxic to human cells, offering a safety advantage.
Benzinga Edge Rankings: Benzinga Edge members get an advantage with real-time portfolio alerts, actionable stock ideas and pro-grade tools that help them profit in any market.
Price Action: According to data from Benzinga Pro, SINT shares are trading higher by 12.47% to $5.14 Wednesday morning. The stock has a 52-week high of $8.60 and a 52-week low of $1.71.
Read Also: LightPath Technologies Stock Is Soaring Today: What’s Fueling The Momentum?
How To Buy SINT Stock
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in SINTX Technologies’ case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock
